Rafferty Asset Management
GBT

Rafferty Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Rafferty Asset Management’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-102,397
Closed -$6.97M – 1177
2022
Q3 		$6.97M Sell
102,397
-69,291
-40% -$3.82M 0.07% 223
2022
Q2 		$5.49M Sell
171,688
-23,605
-12% -$691K 0.05% 266
2022
Q1 		$6.76M Buy
195,293
+1,429
+0.7% +$42.7K 0.04% 281
2021
Q4 		$5.67M Buy
193,864
+78,480
+68% +$2.43M 0.03% 333
2021
Q3 		$2.94M Buy
115,384
+51,200
+80% +$1.5M 0.02% 489
2021
Q2 		$2.25M Sell
64,184
-11,492
-15% -$449K 0.01% 654
2021
Q1 		$3.08M Buy
75,676
+52,698
+229% +$2.42M 0.02% 468
2020
Q4 		$995K Sell
22,978
-14,629
-39% -$721K 0.01% 496
2020
Q3 		$2.07M Buy
37,607
+22,359
+147% +$1.42M 0.03% 407
2020
Q2 		$963K Buy
15,248
+9,239
+154% +$634K 0.01% 559
2020
Q1 		$307K Sell
6,009
-45,020
-88% -$3.02M 0.01% 436
2019
Q4 		$4.06M Sell
51,029
-68,944
-57% -$4.09M 0.06% 161
2019
Q3 		$5.82M Buy
119,973
+28,385
+31% +$1.48M 0.09% 135
2019
Q2 		$4.82M Sell
91,588
-7,561
-8% -$435K 0.08% 172
2019
Q1 		$5.25M Buy
+99,149
New +$4.87M 0.08% 130

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rafferty Asset Management's GBT Position: Q4 2022 in Review

Rafferty Asset Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 102,397 shares — an estimated $6.97M sold.

Rafferty Asset Management first reported a position in GBT in Q1 2019 and held it in 15 quarters. The position peaked at $6.97M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Rafferty Asset Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 102,397 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $6.97M.
  • Rafferty Asset Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2019 and held it in 15 quarters.
  • Rafferty Asset Management's Global Blood Therapeutics, Inc. position peaked at $6.97M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Rafferty Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.